In this context, the presence of increased frequency and number of MDSCs expressing high levels of PD-L1 in the TME of M-Traf3-/- mice would contribute to deeper inhibition of lymphocyte function, leading to enhanced suppression of tumor immunity. The gene discussed is TRAF3; the disease is neoplasm.